Management der ambulant erworbenen Pneumonie bei Kindern und Jugendlichen
摘要
With an age-dependent incidence of 200–1500 cases per 100,000 children/adolescents and year, pediatric community-acquired pneumonia (pCAP) is highly relevant for outpatient and in-hospital healthcare.
MethodThe current state of knowledge is summarized in a recently published updated version of the German-Swiss-Austrian pCAP guidelines with consensus-based practical recommendations.
ResultsThe updated version of the Association of the Scientific Medical Societies in Germany (AWMF) guidelines on the management of community-acquired pneumonia in children and adolescents includes practical recommendations on the following issues:
– clinical classification into three grades of severity (non-severe, severe, very severe) with allocation to corresponding levels of care (outpatient, in-hospital, intensive care unit, ICU),
– primarily clinical diagnosis with only individual criteria for laboratory, pathogen or imaging diagnostics, predominantly for severe pneumonia,
– guidance for indications, selection of active agent, administration route and duration of treatment with antibiotics (empirically calculated with a 5-day course of oral amoxicillin or i.v. ampicillin, in suspected cases of severe Mycoplasma-associated pCAP with oral clarithromycin or doxycycline),
– pulse oximetry cut-off values for hospitalization and oxygen supplementation (≤ 92% should be considered, ≤ 90% indicated),
– management changes after treatment failure or complications,
– preventive and infection control measures.
ConclusionThe aims of the updated guidelines are to improve the practical treatment of children and adolescents with pCAP and to support all professional groups involved. Furthermore, the guidelines should contribute to providing contemporary information for affected patients and their caregivers.